Artialis offers customized solutions and support from preclinical to post-marketing clinical phases, as well as a wide range of clinical, imaging and biochemical markers to support product development.
The GIGA, a research center bringing together 600 researchers in the biomedical field at the University of Liège, located within the University Hospital (CHU Liège), offers space for companies and start-ups, including:
- office and laboratory space
- access to technology platforms and services
- access to various shared laboratories (cell culture, L2 or L3 labs)
Companies located at GIGA :
BelmaTechnologies produces and distributes new implants for laboratory animals (estrogen, progesterone and testosterone).
BCI Pharma is a real platform/technology to deliver novel, potent and selective kinase inhibitors.
CMD-COAT SA is a spin-off company of GIGA/ULiège dedicated to developing a bioactive coating to prevent infection and thrombosis of catheters.
Dendrogenix develop first-in-class molecules, Dendrogenins, to address high unmet medical needs in hearing loss and neurology
LiveDrop is a droplet microfluidics company whose mission is to develop and offer all-in-one integrated flow cytometers based on droplet microfluidics to boost your cell biology and microbiology studies.
THERAtRAME is a spin-off company of GIGA/ULiège which discovers and develops new small molecule inhibitors targeting the tRNA epitranscriptomics to cure patients with untreatable cancer.
VistaCare Medical develops, produces and markets the innovative VistaCare® medical device for the treatment of complex wounds.
XeroThera markets a patented drug delivery technology designed to prevent life-threatening surgical site infections and control surgical pain.